Učitavanje...
CD73 acts as a prognostic biomarker and promotes progression and immune escape in pancreatic cancer
CD73 is a glycosylphosphatidylinositol (GPI)‐anchored protein that attenuates tumour immunity via cooperating with CD39 to generate immunosuppressive adenosine. Therefore, CD73 blockade has been incorporated into clinical trials for cancers based on preclinical efficacy. However, the biological role...
Spremljeno u:
| Izdano u: | J Cell Mol Med |
|---|---|
| Glavni autori: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7412695/ https://ncbi.nlm.nih.gov/pubmed/32643277 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.15500 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|